2016 Hematological Malignancies

Previous Page

Next Page

Page Background

Targeted chemotherapy in clinical development

Goy A, et al.

Blood

. 2010;116(21): Abstract 430.

Polatuzumab

Vedotin

Target CD22

Target CD79b

Antibody-drug conjugates